{"id":"NCT03332303","sponsor":"Prasco LLC","briefTitle":"Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy","officialTitle":"Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multi-Site Study to Evaluate Therapeutic Equivalence of Estradiol Vaginal Cream, USP, 0.01% (Prasco LLC) to Estrace® Cream (Warner Chilcott) in Treatment of Vulvar and Vaginal Atrophy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-26","primaryCompletion":"2018-03-15","completion":"2018-03-15","firstPosted":"2017-11-06","resultsPosted":"2024-05-30","lastUpdate":"2024-05-30"},"enrollment":540,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Vulvar and Vaginal Atrophy"],"interventions":[{"type":"DRUG","name":"Estrace® Cream","otherNames":["Estradiol Vaginal Cream"]},{"type":"DRUG","name":"Estradiol Vaginal Cream","otherNames":[]},{"type":"DRUG","name":"Vehicle Cream","otherNames":["Placebo"]}],"arms":[{"label":"Experimental: Estradiol Vaginal Cream, USP, 0.01% (Prasco LLC)","type":"EXPERIMENTAL"},{"label":"Active Comparator: Estrace® Cream","type":"ACTIVE_COMPARATOR"},{"label":"Placebo Comparator: Placebo (Test vehicle cream) Vaginal Cream","type":"PLACEBO_COMPARATOR"}],"summary":"The objectives of this study are to evaluate the therapeutic equivalence of the Test formulation, Estradiol Vaginal Cream 0.01% (Prasco, LLC) to the marketed product, Estrace® Cream (estradiol vaginal cream, 0.01%) in patients with vulvar and vaginal atrophy, and compare the safety of Test, Reference and Placebo treatments in patients with vulvar and vaginal atrophy.","primaryOutcome":{"measure":"The Primary Efficacy Endpoint","timeFrame":"Study Day 8 or Study Day 9","effectByArm":[{"arm":"Experimental: Estradiol Vaginal Cream, USP, 0.01% (Prasco LLC)","deltaMin":49,"sd":null},{"arm":"Active Comparator: Estrace® Cream","deltaMin":59,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"30 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":27,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":215},"commonTop":["Abdominal pain","Headache","Pelvic pain","Breast tenderness","Abdominal distention"]}}